Carcinoid syndrome echocardiography or ultrasound: Difference between revisions
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
=Transesophageal echocardiography= | =Transesophageal echocardiography= | ||
*TEE is primarily used intraoperatively to image the patient with carcinoid heart disease during valve replacement surgery. | *TEE is primarily used intraoperatively to image the patient with carcinoid heart disease during valve replacement surgery.<ref name="BanzaliTiwari2007">{{cite journal|last1=Banzali|first1=Franklin M.|last2=Tiwari|first2=Anil K.|last3=Frantz|first3=Robert|last4=D’Attellis|first4=Nicola|title=Valvular Heart Disease Caused by Carcinoid Syndrome: Emphasis on the Use of Intraoperative Transesophageal Echocardiography|journal=Journal of Cardiothoracic and Vascular Anesthesia|volume=21|issue=6|year=2007|pages=855–857|issn=10530770|doi=10.1053/j.jvca.2007.06.014}}</ref> | ||
*TEE may provide incremental assessment of the degree of cardiac valve involvement and the atrial septal anatomy in patients with carcinoid heart disease. | *TEE may provide incremental assessment of the degree of cardiac valve involvement and the atrial septal anatomy in patients with carcinoid heart disease. | ||
=Cardiac magnetic resonance= | =Cardiac magnetic resonance= | ||
*It can be used to evaluate the pulmonary valve, identify cardiac metastases, and assess right ventricular size and function.<ref name="pmid16272847">{{cite journal |vauthors=Bastarrika G, Cao MG, Cano D, Barba J, de Buruaga JD |title=Magnetic resonance imaging diagnosis of carcinoid heart disease |journal=J Comput Assist Tomogr |volume=29 |issue=6 |pages=756–9 |date=2005 |pmid=16272847 |doi= |url=}}</ref> | *It can be used to evaluate the pulmonary valve, identify cardiac metastases, and assess right ventricular size and function.<ref name="pmid16272847">{{cite journal |vauthors=Bastarrika G, Cao MG, Cano D, Barba J, de Buruaga JD |title=Magnetic resonance imaging diagnosis of carcinoid heart disease |journal=J Comput Assist Tomogr |volume=29 |issue=6 |pages=756–9 |date=2005 |pmid=16272847 |doi= |url=}}</ref> | ||
Revision as of 22:44, 22 April 2019
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome echocardiography or ultrasound |
|
Carcinoid syndrome echocardiography or ultrasound in the news |
|
Risk calculators and risk factors for Carcinoid syndrome echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Trans-thoracic echocardiography findings include thickening and retraction of immobile tricuspid valve leaflets with associated tricuspid regurgitation and immobility of the pulmonary valve cusps. Trans-esophageal echoardiography findings provide incremental assessment of the degree of cardiac valve involvement and the atrial septal anatomy in patients with carcinoid heart disease.
Echocardiography
Transthoracic echocardiography
- Should be performed in all patients with carcinoid syndrome and high suspicion of carcinoid heart disease such as clinical features or raised NT-proBNP and/or 5-HIAA levels.
- Findings includes followings:
- Thickening and retraction of immobile tricuspid valve leaflets with associated tricuspid regurgitation, which is severe at the time of identification in 90 percent of patients.
- Immobility of the pulmonary valve cusps.
Transesophageal echocardiography
- TEE is primarily used intraoperatively to image the patient with carcinoid heart disease during valve replacement surgery.[3]
- TEE may provide incremental assessment of the degree of cardiac valve involvement and the atrial septal anatomy in patients with carcinoid heart disease.
Cardiac magnetic resonance
- It can be used to evaluate the pulmonary valve, identify cardiac metastases, and assess right ventricular size and function.[4]
References
- ↑ Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK (April 1993). "Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients". Circulation. 87 (4): 1188–96. PMID 7681733.
- ↑ Stougiannos, Pavlos; Michas, George; Evdoridis, Constantinos; Arapantoni-Dadioti, Petroula; Tolios, Panagiotis; Kaplanis, Ioannis; Trikas, Athanasios (2017). "Carcinoid heart disease in an elderly female patient: the value of transthoracic echocardiography". Hellenic Journal of Cardiology. 58 (1): 65–68. doi:10.1016/j.hjc.2017.01.018. ISSN 1109-9666.
- ↑ Banzali, Franklin M.; Tiwari, Anil K.; Frantz, Robert; D’Attellis, Nicola (2007). "Valvular Heart Disease Caused by Carcinoid Syndrome: Emphasis on the Use of Intraoperative Transesophageal Echocardiography". Journal of Cardiothoracic and Vascular Anesthesia. 21 (6): 855–857. doi:10.1053/j.jvca.2007.06.014. ISSN 1053-0770.
- ↑ Bastarrika G, Cao MG, Cano D, Barba J, de Buruaga JD (2005). "Magnetic resonance imaging diagnosis of carcinoid heart disease". J Comput Assist Tomogr. 29 (6): 756–9. PMID 16272847.